The diabetes division will separate from its parent company. Could this unlock faster innovation—or is it more of the same with a new name?
An exclusive behind-the-scenes tour of Medtronic’s unreleased implantable CGM and the early days of its pump innovation.
The company will now open the waitlist for its newly FDA cleared CGM to current users after user feedback.
The major insulin pump manufacturer sent out a survey asking its users which color they prefer for its upcoming tubeless pump.
Medtronic's upcoming lineup of diabetes tech includes two new insulin pumps—one being its first-ever tubeless option—along with updates to its continuous glucose monitors.
The disposable sensor is 50% smaller and works with Medtronic's smart insulin pen.
